Erez Aminov - Dec 31, 2024 Form 5 Insider Report for Telomir Pharmaceuticals, Inc. (TELO)

Role
CEO and Chairman, Director
Signature
/s/ Erez Aminov
Stock symbol
TELO
Transactions as of
Dec 31, 2024
Transactions value $
-$2,442
Form type
5
Date filed
2/4/2025, 04:05 PM
Previous filing
Dec 10, 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TELO Common Stock Sale -$1.2K -200 -0.67% $6.01 29.6K Aug 19, 2024 Direct F1
transaction TELO Common Stock Sale -$1.24K -200 -0.67% $6.20 29.6K Aug 19, 2024 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the sale of common stock that should have been reported on Form 4.